tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IMGN

Two option delistings on February 21st
The FlyTwo option delistings on February 21st
1y ago
IMGN
ImmunoGen Finalizes Merger, Amends Operations, and Delists Shares
PremiumCompany Announcements
ImmunoGen Finalizes Merger, Amends Operations, and Delists Shares
1y ago
8K
IMGN
AbbVie completes the acquisition of ImmunoGen
PremiumThe Fly
AbbVie completes the acquisition of ImmunoGen
1y ago
ABBV
IMGN
ImmunoGen Set to Merge with AbbVie, Awaiting Final Approval
PremiumCompany Announcements
ImmunoGen Set to Merge with AbbVie, Awaiting Final Approval
1y ago
8K
IMGN
Is IMGN a Buy, Before Earnings?
PremiumPre-Earnings
Is IMGN a Buy, Before Earnings?
1y ago
IMGN
Immunogen Shareholders Approve Merger with AbbVie Inc.
PremiumCompany AnnouncementsImmunogen Shareholders Approve Merger with AbbVie Inc.
1y ago
8K
IMGN
ImmunoGen’s Merger with AbbVie Awaits Shareholder Approval
Premium
Company Announcements
ImmunoGen’s Merger with AbbVie Awaits Shareholder Approval
1y ago
8K
IMGN
Immunogen Merges with AbbVie, Responds to Shareholder Complaints
Premium
Market News
Immunogen Merges with AbbVie, Responds to Shareholder Complaints
1y ago
8K
IMGN
The biopharma stocks to own in 2024, according to Morgan Stanley
PremiumThe Fly
The biopharma stocks to own in 2024, according to Morgan Stanley
1y ago
BMY
JNJ
The biopharma stocks to own in 2024, according to Morgan Stanley
PremiumThe Fly
The biopharma stocks to own in 2024, according to Morgan Stanley
1y ago
BMY
JNJ
ImmunoGen presents findings from newly diagnosed AML cohorts in Phase 1b/2 study
PremiumThe Fly
ImmunoGen presents findings from newly diagnosed AML cohorts in Phase 1b/2 study
1y ago
IMGN
M & A News: AbbVie (NYSE:ABBV) Doubles Down on Acquisitions, Buys CERE for $8.7B
PremiumMarket News
M & A News: AbbVie (NYSE:ABBV) Doubles Down on Acquisitions, Buys CERE for $8.7B
2y ago
ABBV
CERE
ImmunoGen’s sBLA for Elahere in ovarian cancer granted priority review by FDA
PremiumThe FlyImmunoGen’s sBLA for Elahere in ovarian cancer granted priority review by FDA
2y ago
IMGN
ImmunoGen downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
ImmunoGen downgraded to Neutral from Overweight at Piper Sandler
2y ago
ABBV
IMGN
ImmunoGen downgraded to Equal Weight from Overweight at Barclays
Premium
The Fly
ImmunoGen downgraded to Equal Weight from Overweight at Barclays
2y ago
IMGN
ImmunoGen downgraded to Equal Weight from Overweight at Barclays
PremiumThe Fly
ImmunoGen downgraded to Equal Weight from Overweight at Barclays
2y ago
IMGN
ImmunoGen downgraded to Hold from Buy at Jefferies
PremiumThe Fly
ImmunoGen downgraded to Hold from Buy at Jefferies
2y ago
IMGN
AbbVie Stock (NYSE:ABBV): Bet on a Smart Drugmaker and Dealmaker
PremiumStock Analysis & Ideas
AbbVie Stock (NYSE:ABBV): Bet on a Smart Drugmaker and Dealmaker
2y ago
ABBV
IMGN
ImmunoGen downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
ImmunoGen downgraded to Neutral from Buy at Guggenheim
2y ago
IMGN
ImmunoGen downgraded to Market Perform from Outperform at BMO Capital
PremiumThe FlyImmunoGen downgraded to Market Perform from Outperform at BMO Capital
2y ago
IMGN
ImmunoGen downgraded to Hold from Buy at Deutsche Bank
Premium
The Fly
ImmunoGen downgraded to Hold from Buy at Deutsche Bank
2y ago
ABBV
IMGN
ImmunoGen downgraded to Hold from Buy at Jefferies
Premium
The Fly
ImmunoGen downgraded to Hold from Buy at Jefferies
2y ago
IMGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >